PrEP at a Syringe Services Program

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

November 11, 2024

Study Completion Date

November 11, 2024

Conditions
HivSubstance Use Disorders
Interventions
DRUG

Descovy 200Mg 25Mg Tablet

daily Descovy tab by mouth

BEHAVIORAL

PrEP

PrEP will be provided in a community setting by community-based harm reduction program.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER